Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Classification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds.

Hailey JR, Walker NJ, Sells DM, Brix AE, Jokinen MP, Nyska A.

Toxicol Pathol. 2005;33(1):165-74.

PMID:
15805068
2.

Mechanisms of exocrine pancreatic toxicity induced by oral treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Harlan Sprague-Dawley Rats.

Yoshizawa K, Marsh T, Foley JF, Cai B, Peddada S, Walker NJ, Nyska A.

Toxicol Sci. 2005 May;85(1):594-606. Epub 2005 Feb 16.

PMID:
15716480
3.

Dose-additive carcinogenicity of a defined mixture of "dioxin-like compounds".

Walker NJ, Crockett PW, Nyska A, Brix AE, Jokinen MP, Sells DM, Hailey JR, Easterling M, Haseman JK, Yin M, Wyde ME, Bucher JR, Portier CJ.

Environ Health Perspect. 2005 Jan;113(1):43-8.

4.

Gingival carcinogenicity in female Harlan Sprague-Dawley rats following two-year oral treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds.

Yoshizawa K, Walker NJ, Jokinen MP, Brix AE, Sells DM, Marsh T, Wyde ME, Orzech D, Haseman JK, Nyska A.

Toxicol Sci. 2005 Jan;83(1):64-77. Epub 2004 Oct 27. Erratum in: Toxicol Sci. 2005 Feb;83(2):405-6.

PMID:
15509667
5.
6.

Exocrine pancreatic pathology in female Harlan Sprague-Dawley rats after chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds.

Nyska A, Jokinen MP, Brix AE, Sells DM, Wyde ME, Orzech D, Haseman JK, Flake G, Walker NJ.

Environ Health Perspect. 2004 Jun;112(8):903-9.

7.

Evaluation of toxic equivalency factors for induction of cytochromes P450 CYP1A1 and CYP1A2 enzyme activity by dioxin-like compounds.

Toyoshiba H, Walker NJ, Bailer AJ, Portier CJ.

Toxicol Appl Pharmacol. 2004 Jan 15;194(2):156-68.

PMID:
14736496
8.
9.

Follicular epithelial cell hypertrophy induced by chronic oral administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Harlan Sprague-Dawley rats.

Tani Y, Maronpot RR, Foley JF, Haseman JK, Walker NJ, Nyska A.

Toxicol Pathol. 2004 Jan-Feb;32(1):41-9.

PMID:
14713547
10.
11.

Quality review procedures necessary for rodent pathology databases and toxicogenomic studies: the National Toxicology Program experience.

Boorman GA, Haseman JK, Waters MD, Hardisty JF, Sills RC.

Toxicol Pathol. 2002 Jan-Feb;30(1):88-92. Review.

PMID:
11890481
12.

Sensitivity to the dopaminergic regulation of prepulse inhibition in rats: evidence for genetic, but not environmental determinants.

Swerdlow NR, Platten A, Kim YK, Gaudet I, Shoemaker J, Pitcher L, Auerbach P.

Pharmacol Biochem Behav. 2001 Oct-Nov;70(2-3):219-26.

PMID:
11701191
14.

Hepatic stem cells: a review.

Vessey CJ, de la Hall PM.

Pathology. 2001 May;33(2):130-41. Review.

PMID:
11358043
15.
16.

Ah receptor signaling pathways.

Schmidt JV, Bradfield CA.

Annu Rev Cell Dev Biol. 1996;12:55-89. Review.

PMID:
8970722
17.

Classification of cystic keratinizing squamous lesions of the rat lung: report of a workshop.

Boorman GA, Brockmann M, Carlton WW, Davis JM, Dungworth DL, Hahn FF, Mohr U, Reichhelm HB, Turusov VS, Wagner BM.

Toxicol Pathol. 1996 Sep-Oct;24(5):564-72.

PMID:
8923677
18.

Evidence for the role of the Ah receptor in response to dioxin.

Birnbaum LS.

Prog Clin Biol Res. 1994;387:139-54. Review. No abstract available.

PMID:
7972244
19.
20.

Supplemental Content

Support Center